Cookie Consent by

AiPBAND (An Integrated Platform for Developing Brain Cancer Diagnostics Techniques)

Marie Curie Early Stage Researcher Fellowship in clinical evaluation of tumour biomarkers and clinical investigation of the diagnostic system

AiPBAND (An Integrated Platform for Developing Brain Cancer Diagnostics Techniques) is an Innovative Training Network (ITN) funded under the EU H2020 Marie Skłodowska-Curie Actionsto train fourteen Early Stage Researchers (ESRs). It brings together leading academic and industrial experts in Europe and China, and build a triple-i (interdisciplinary, intersectoral and international) research & training platform with the required multidisciplinary expertise and cutting-edge technologies

We are looking for a highly motivated and committed candidate to participate in this innovative research and training programme. The ESR will be one of the fourteen ESRs in the AiPBAND network. The ESR will be based mainly at MTA Italy and can register as a PhD student at the University of Plymouth on satisfying the enrollment criteria of the Doctoral College.

In MTA we have strong experience in the clinical research field both from the methodological planning and the operational implementation point of view. Plymouth University has a centre of excellence for Brain Tumours. The aim of this ESR project is to develop, set up and implement documents and tools e.g. virtual biobanks as well as clinical studies in the frame of the comprehensive clinical validation plan for diagnostic tumour biomarkers and AiPBAND diagnostic system. You will be working together with other researchers, have a number of secondment opportunities with partner institutions and attend a series of training events of the AiPBAND network.

This is a full-time position for 36 months on a fixed term contract of three years starting 1st June 2018 or as soon as possible thereafter.
For an informal discussion please contact MTA referents at:
To apply, please send your CV and cover letter to:

Talk about us...

Wed 19th, 2018 - Press Release

Gliomas are a range of devastating and progressive brain tumors affecting around 25,000 people each year in Europe and responsible for the majority of deaths from primary brain tumors. Nine research institutes and three private sector organizations have joined together to address this problem as Project AiPBAND (An Integrated Platform for Developing Brain Cancer Diagnostics Techniques), with its mission to improve technologies for the early diagnosis of brain tumors using molecular biomarkers in the blood. The project...

Mar 3rd, 2018 - Resto del Carlino